GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes.

Autor: Li P; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia.; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville., Li Z; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia., Staton E; Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, Georgia., Umpierrez GE; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia., Davis G; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia., Shao H; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia.; Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia., Pasquel FJ; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia.; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia.
Jazyk: angličtina
Zdroj: JAMA [JAMA] 2024 Nov 19; Vol. 332 (19), pp. 1667-1669.
DOI: 10.1001/jama.2024.18581
Databáze: MEDLINE